Aguirre J A, Hedlund P B, Narváez J A, Bunnemann B, Ganten D, Fuxe K
Department of Physiology, University of Málaga, Spain.
Brain Res. 1995 Jul 3;684(2):159-64. doi: 10.1016/0006-8993(95)00408-i.
The C-terminal NPY fragment (13-36)[NPY-(13-36)], a Y2 receptor agonist, elicits vasopressor responses upon central administration. The cardiovascular responses of NPY-(13-36) together with the distribution of NPY receptor subtypes within the nucleus tractus solitarius (nTS) have therefore been studied in spontaneously hypertensive rats (SHR). NPY-(13-36) was injected intracerebro-ventricularly in different doses (7.5 to 3000 pmol) in awake, unrestrained rats to evaluate the cardiovascular effects. NPY receptor subtypes were studied by autoradiography using [125I]peptide YY ([125I]PYY) as a radioligand and by masking the NPY Y1 and Y2 receptor subtypes with unlabelled [Leu31,Pro43]NPY and NPY-(13-36) respectively. In both male SHR and age-matched male normotensive Wistar-Kyoto rats (WKY) NPY-(13-36) injections elicited vasopressor effects. In WKY this effect was dose-dependent and became significant at doses from 75 pmol, whereas in the SHR the vasopressor effect had a longer duration than in the WKY and became significant at lower doses (25 pmol) but associated with the development of an early ceiling effect. The heart rate was unaffected in both groups of rats. Total specific [125I]PYY binding in the nTS was 25% higher in SHR than in WKY rats. By masking the Y1 and Y2 receptor subtypes respectively it could be shown that this difference was due to an increase in Y2 receptor binding within the nTS. The present results give evidence for an increased potency but not an increased efficacy of NPY-(13-36) in inducing a pressor response in the SHR associated with a longer duration as compared with the WKY rats.(ABSTRACT TRUNCATED AT 250 WORDS)
C 末端神经肽 Y 片段(13 - 36)[NPY - (13 - 36)]是一种 Y2 受体激动剂,经中枢给药后可引发升压反应。因此,研究人员在自发性高血压大鼠(SHR)中研究了 NPY - (13 - 36)的心血管反应以及孤束核(nTS)内 NPY 受体亚型的分布情况。将不同剂量(7.5 至 3000 皮摩尔)的 NPY - (13 - 36)经脑室内注射到清醒、不受约束的大鼠体内,以评估其心血管效应。通过放射自显影技术,使用[125I]肽 YY([125I]PYY)作为放射性配体,并分别用未标记的[Leu31,Pro43]NPY 和 NPY - (13 - 36)掩盖 NPY Y1 和 Y2 受体亚型,来研究 NPY 受体亚型。在雄性 SHR 和年龄匹配的雄性正常血压的Wistar - Kyoto 大鼠(WKY)中,注射 NPY - (13 - 36)均引发了升压效应。在 WKY 大鼠中,这种效应呈剂量依赖性,在 75 皮摩尔的剂量时变得显著;而在 SHR 中,升压效应的持续时间比 WKY 大鼠更长,在较低剂量(25 皮摩尔)时就变得显著,但伴随着早期的效应上限的出现。两组大鼠的心率均未受影响。SHR 的 nTS 中总的特异性[125I]PYY 结合比 WKY 大鼠高 25%。通过分别掩盖 Y1 和 Y2 受体亚型可以发现,这种差异是由于 nTS 内 Y2 受体结合增加所致。目前的结果表明,与 WKY大鼠相比,NPY - (13 - 36)在 SHR 中诱导升压反应的效力增加,但效果并未增强,且持续时间更长。(摘要截选至 250 字)